Tokyo, Sept. 21 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059134) titled 'Neuromuscular Control during Uneven surface walking under different conditions' on Sept. 21.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Single blind -participants are blinded
Control - Placebo
Primary Sponsor:
Institute - Niigata University of Health and Welfare
Condition:
Condition - Healthy adults
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To elucidate the mechanisms of neuromuscular control in walking on uneven terrain.
Basic objectives2 - Others
Intervention:
Interventions/Control_1 - Normal gait
Interventions/Control_2 - Gait with no arm swing
Eligibility:
Age-lower limit - 18
years-old
Gender - Male and Female
Key inclusion criteria - Right-hand and leg dominant
Able to understand instructions
Key exclusion criteria - With orthopedic or neurological diseases or a history of such diseases
Target Size - 60
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 08 Month 25 Day
Anticipated trial start date - 2025 Year 10 Month 10 Day
Last follow-up date - 2027 Year 01 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067645
Disclaimer: Curated by HT Syndication.
